Neoadjuvant chemotherapy paclitaxel + doxorubicin (PD) vs fluorouracil + doxorubicin + cyclophosphamide (FAC) in locally advanced breast cancer: Clinical and pathological response by Semiglazov, V.F., Bojok, A.A., Arsumanov, A.S., Ivanova, O.A., Ivanov, V.G., Semiglazov, V.V., Pozharissky, K.M., Topuzov, E.E., Nurgaziev, K.S., Paltuev, R.M.

Get full text